This article on the discovery at the MDI Biological Laboratory by Kevin Strange, Ph.D., and Viravuth Yin, Ph.D., of MSI-1436, a regenerative medicine drug candidate for the treatment of heart disease, has been reprinted from Scientific American in Spektrum der Wissenschaft, the largest of Scientific American’s international editions.
This edition of the Biomedical Beat blog, published by the National Institute of General Medical Sciences, profiles MDI Biological Laboratory regenerative biologist Voot Yin.
This article from the Japanese edition of Scientific American by Kevin Strange, Ph.D., and Viravuth Yin, Ph.D., of the MDI Biological Laboratory discusses their discovery of a new regenerative medicine drug candidate to restore heart issue after a heart attack.
In this “marquee” article in Scientific American, Kevin Strange, Ph.D., and Viravuth Yin, Ph.D., write about the discovery of MSI-1436, a regenerative medicine drug candidate to regenerate heart muscle tissue after a heart attack. Strange is the co-founder, president and CEO of Novo Biosciences and the former president of the MDI Biological Laboratory; Yin is the co-founder and chief scientific officer of Novo and an associate professor at the MDI Biological Laboratory.
In this blog about the April edition of Scientific American, editor-in-chief Mariette DiChristina promos an article, “A Shot at Regeneration,” about a regenerative medicine drug candidate, MSI-1436, developed at the MDI Biological Laboratory to treat heart attack patients after a heart attack.
Bar Harbor biotech firm Novo Biosciences has made substantial progress in bringing the drug candidate it’s developing to activate injured tissue regeneration, including heart muscle tissue damaged by heart attack, to market.
The Working Waterfront, a publication of the Island Institute, looks at MSI-1436, a drug candidate discovered by MDI Biological Laboratory scientists Kevin Strange, Ph.D., and Voot Yin, Ph.D., with collaborator Michael Zasloff, M.D., Ph.D. The compound promises to regenerate heart muscle tissue after a heart attack.
There are many parts of the genetic code in humans and other organisms that we still fail to understand. Scientists had previously labeled a large portion of the genetic material in zebrafish “junk” because its function was not known to us. The article named “New Genetic Regulators of Regeneration Identified” describes how a recent study explains that these “junk” genes that were previously overlooked, carry out the very important function of cardiac regeneration.
Scientists at the MDI Biological Laboratory and the University of Maine have discovered that genetic material in the cell that was previously thought to be “junk” because of its apparent lack of function likely plays a part in regulating genetic circuits responsible for regeneration in highly regenerative animals.
We may one day have access to drugs that help trigger regeneration in damaged tissues and organs thanks to scientists from the MDI Biological Laboratory and University of Maine.